NEWM&A

Arcutis Biotherapeutics (ARQT) Form 144 Filing on June 17

Published on 6/18/2026

#ARQT#Form144#insidertrading#filing
Arcutis Biotherapeutics (ARQT) Form 144 Filing on June 17

AI Summary

Arcutis Biotherapeutics (ARQT) filed Form 144 on June 17. This form indicates the intention to sell a specified number of shares in the public market. Such filings are typically done by insiders, including executives or major shareholders, and can signify potential selling pressure on the stock. Monitoring these filings is crucial as they can affect investor sentiment and trading activity surrounding the stock.

Source: Read original article (opens in new tab)

Related News

Victoria's Secret (VSCO) Form 144 Filed on June 17
Markets

Victoria's Secret (VSCO) Form 144 Filed on June 17

Jun 18

HYATT (H) Form 144 Filed on June 17 Reports Insider Activity
Markets

HYATT (H) Form 144 Filed on June 17 Reports Insider Activity

Jun 18

ETSY (ETSY) Form 144 Filed on June 17 Reveals Key Details
Markets

ETSY (ETSY) Form 144 Filed on June 17 Reveals Key Details

Jun 18

Howard Hughes Corporation (HHC) Form 144 Filed June 17, 2023
Regulation

Howard Hughes Corporation (HHC) Form 144 Filed June 17, 2023

Jun 18